Philly nonprofit gets $48 million to use AI to find new uses for approved drugs

Full Article

Every Cure, a Philadelphia-based nonprofit, has been awarded a $48.3 million federal contract to develop an AI-driven program aimed at repurposing existing medications for rare diseases. This innovative approach will utilize algorithms to analyze thousands of approved drugs and identify potential new uses, streamlining a traditionally slow process. The initiative is backed by the Advanced Research Projects Agency for Health, which seeks to accelerate medical breakthroughs.

The project aims to create an open-source database and a portal for medical professionals and patients to contribute ideas. By generating predictive efficacy scores, Every Cure will evaluate which drugs have the highest potential for repurposing, ultimately recommending candidates for clinical trials. This could revolutionize treatment options for patients with rare diseases, highlighting the untapped potential of existing medications.

• Every Cure aims to automate drug repurposing using AI algorithms.

• The project will create a database for drug repurposing and patient input.

Key AI Terms Mentioned in this Article

Artificial Intelligence

In this context, AI is used to analyze drug data and identify new treatment possibilities.

Predictive Efficacy Scores

This scoring will guide decisions on which drugs to consider for further clinical trials.

Companies Mentioned in this Article

Every Cure

Every Cure is leveraging AI to find new uses for existing medications, aiming to improve treatment options for rare diseases.

Advanced Research Projects Agency for Health

The agency supports projects like Every Cure's to expedite breakthroughs in medical treatments.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 4month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 4month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 4month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 4month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics